Oruka Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 02/12/2026 | 3.54 M | $107.28 B | 60.55% | 8.03% |
| VANGUARD GROUP INC | 01/29/2026 | 2.45 M | $74.37 M | 38.10% | 5.57% |
| DEEP TRACK CAPITAL, LP | 02/13/2026 | 2.16 M | $65.52 M | -18.58% | 4.91% |
| 02/12/2026 | 1.55 M | $47.05 M | 100.00% | 3.52% | |
| STATE STREET CORP | 02/13/2026 | 1.38 M | $41.94 M | 112.24% | 3.14% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 942.51 K | $28.57 B | 36.60% | 2.14% |
| FRANKLIN RESOURCES INC | 02/11/2026 | 938.42 K | $28.44 M | -11.95% | 2.13% |
| AFFINITY ASSET ADVISORS, LLC | 02/13/2026 | 802.34 K | $24.32 M | -16.35% | 1.82% |
| MERCER GLOBAL ADVISORS INC /ADV | 02/18/2026 | 745.28 K | $22.59 M | -12.57% | 1.69% |
| CITADEL ADVISORS LLC | 02/17/2026 | 726.12 K | $22.01 B | 129.14% | 1.65% |
| AVIDITY PARTNERS MANAGEMENT LP | 02/13/2026 | 660.42 K | $20.02 M | 0.00% | 1.50% |
| SYNERGY ASSET MANAGEMENT, LLC | 01/13/2026 | 458.95 K | $13.91 M | 100.00% | 1.04% |
| SR ONE CAPITAL MANAGEMENT, LP | 02/12/2026 | 430.33 K | $13.04 M | 0.00% | 0.98% |
| CANDRIAM S.C.A. | 02/13/2026 | 400.51 K | $12.14 M | 9.13% | 0.91% |
| CABLE CAR CAPITAL LLC | 02/17/2026 | 400.00 K | $12.12 B | -20.00% | 0.91% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 329.50 K | $9.99 M | 33.44% | 0.75% |
| UBS GROUP AG | 01/29/2026 | 271.01 K | $8.21 B | 213.09% | 0.62% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 02/12/2026 | 190.00 K | $5.76 M | 100.00% | 0.43% |
| BARCLAYS PLC | 02/13/2026 | 173.33 K | $5.25 M | 81.82% | 0.39% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 139.27 K | $4.22 M | 76.30% | 0.32% |
| MOODY ALDRICH PARTNERS LLC | 01/30/2026 | 126.81 K | $3.84 M | 100.00% | 0.29% |
| MORGAN STANLEY | 02/13/2026 | 122.20 K | $3.70 M | -9.37% | 0.28% |
| DEUTSCHE BANK AG\ | 02/11/2026 | 119.33 K | $3.62 M | 439.49% | 0.27% |
| 02/13/2026 | 118.52 K | $3.59 B | 100.00% | 0.27% | |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 114.17 K | $3.46 M | 61.64% | 0.26% |
| ALYESKA INVESTMENT GROUP, L.P. | 02/13/2026 | 100.00 K | $3.03 M | 100.00% | 0.23% |
| GOLDMAN SACHS GROUP INC | 02/10/2026 | 93.00 K | $2.82 M | 370.27% | 0.21% |
| NUVEEN, LLC | 02/12/2026 | 86.35 K | $2.62 B | 144.52% | 0.20% |
| SECURE ASSET MANAGEMENT, LLC | 01/20/2026 | 81.66 K | $2.48 M | 100.00% | 0.19% |
| TD ASSET MANAGEMENT INC | 02/10/2026 | 79.90 K | $2.42 M | 74.16% | 0.18% |
| ABRDN PLC | 01/16/2026 | 75.68 K | $2.29 M | 0.00% | 0.17% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 02/13/2026 | 61.36 K | $1.80 M | 18.21% | 0.14% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 58.72 K | $1.78 B | 100.00% | 0.13% |
| AMERICAN CENTURY COMPANIES INC | 02/13/2026 | 57.08 K | $1.73 M | 67.34% | 0.13% |
| KENNEDY CAPITAL MANAGEMENT LLC | 02/13/2026 | 48.69 K | $1.48 M | 0.87% | 0.11% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 43.26 K | $1.31 M | 107.43% | 0.10% |
| SWISS NATIONAL BANK | 02/12/2026 | 43.00 K | $1.30 M | 100.00% | 0.10% |
| VOYA INVESTMENT MANAGEMENT LLC | 02/12/2026 | 42.50 K | $1.29 M | 100.00% | 0.10% |
| RHUMBLINE ADVISERS | 02/13/2026 | 41.02 K | $1.24 M | 35.25% | 0.09% |
| ALPS ADVISORS INC | 02/12/2026 | 39.75 K | $1.20 M | 100.00% | 0.09% |
| RAFFERTY ASSET MANAGEMENT, LLC | 02/13/2026 | 38.49 K | $1.17 M | 200.97% | 0.09% |
| VERITION FUND MANAGEMENT LLC | 02/13/2026 | 35.71 K | $1.08 M | 100.00% | 0.08% |
| FINANCIAL ENHANCEMENT GROUP LLC | 01/23/2026 | 31.29 K | $1.08 M | -4.65% | 0.07% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 02/13/2026 | 29.18 K | $849.84 K | 0.00% | 0.07% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 28.57 K | $865.84 M | 0.00% | 0.06% |
| SQUAREPOINT OPS LLC | 02/13/2026 | 27.67 K | $838.71 K | 100.00% | 0.06% |
| METLIFE INVESTMENT MANAGEMENT, LLC | 02/12/2026 | 21.36 K | $647.48 K | 29.36% | 0.05% |
| JPMORGAN CHASE & CO | 02/11/2026 | 20.42 K | $618.84 K | 41.01% | 0.05% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 02/13/2026 | 20.00 K | $606.20 K | 100.00% | 0.05% |
| LEGAL & GENERAL GROUP PLC | 02/09/2026 | 18.74 K | $568.13 K | 656.72% | 0.04% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Oruka Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 108 institutional investors and hedge funds held shares of Oruka Therapeutics Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 3.54 M
VANGUARD GROUP INC: 2.45 M
Deep Track Capital, LP: 2.16 M
STATE STREET CORP: 1.38 M
GEODE CAPITAL MANAGEMENT, LLC: 942,507
FRANKLIN RESOURCES INC: 938,421
27.14% of Oruka Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 19.19 M shares in the last 24 months. This purchase volume represents approximately $619.17 M in transactions.